PLX : Insider Transactions for Protalix Biotherapeutics | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Protalix Biotherapeutics (PLX)

$0.26 0.00 (0.00%) as of 4:30 Fri 2/14

Download

Exchange:

American Stock Exchange

Security Type:

Common

Shares Out:

45,560,000

Market Cap:

12.06(M)

Last Volume:

1,167,076

Avg Vol:

536,427

52 Week Range:

$0.2646 - $0.2646

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Protalix BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Co.'s proprietary ProCellEx platform is being used to manufacture its marketed product, Elelyso®, for the treatment of Gaucher disease. Co. is also developing, via ProCellEx, a pipeline of products. Co.'s clinical development program for pegunigalsidase alfa, or PRX-102, for the potential treatment of Fabry disease. In addition, Co. is developing uricase, or PRX-115, for the treatment of refractory gout.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	64,516	174,516
Total Buy Value	$0	$0	$90,484	$246,299
Total People Bought	0	0	1	2
Total Buy Transactions	0	0	1	2
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-18	2023-11-17	2023-05-19	2022-05-19

Adjust Filter Settings

Records found: 182

Page 5 of 8

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-18

4

S

$6.00

$468,500

I/I

(76,989)

8,731,913

-

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-13

4

S

$5.90

$899,925

I/I

(150,000)

9,040,854

-

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-12

4

S

$6.06

$924,069

I/I

(150,000)

9,190,854

-

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-11

4

S

$5.90

$160,343

I/I

(26,695)

9,340,854

-

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-10

4

S

$6.04

$628,163

I/I

(102,443)

9,385,106

-

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-10

4

S

$6.30

$112,110

I/I

(17,557)

9,367,549

-

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-07

4

S

$6.39

$96,929

I/I

(15,000)

9,487,549

-

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-06

4

S

$6.80

$29,512

I/I

(4,340)

9,502,549

-

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-05

4

S

$6.80

$247,480

I/I

(35,950)

9,506,889

-

Frost Gamma Investment Trust

10% Owner

– – •

2009-08-04

4

S

$7.00

$510,810

I/I

(71,934)

9,542,839

-

VP, Chief Financial Officer

• – –

2009-07-07

4

D

$4.95

$60,474

I/I

(12,217)

0

-

VP, Chief Financial Officer

• – –

2009-07-07

4

OE

$0.97

$60,475

I/I

62,217

0

-

VP, Chief Financial Officer

• – –

2009-07-07

4

AS

$5.01

$50,100

I/I

(10,000)

0

-

Almon Einat Brill

VP, Product Development

• – –

2009-07-07

4

D

$4.95

$23,869

I/I

(4,822)

0

-

Almon Einat Brill

VP, Product Development

• – –

2009-07-07

4

OE

$0.40

$23,869

I/I

59,822

0

-

Almon Einat Brill

VP, Product Development

• – –

2009-07-07

4

AS

$4.95

$54,450

I/I

(11,000)

0

-

VP, Chief Financial Officer

• – –

2009-07-06

4

AS

$5.13

$205,200

I/I

(40,000)

0

-

Shaaltiel Yoseph

Executive VP, R&D

• • –

2009-07-06

4

AS

$4.95

$509,400

D/D

(100,000)

1,363,754

-

Almon Einat Brill

VP, Product Development

• – –

2009-07-06

4

AS

$5.13

$225,720

I/I

(44,000)

0

-

Almon Einat Brill

VP, Product Development

• – –

2009-05-18

4

S

$4.00

$160,000

I/I

(40,000)

0

-

Almon Einat Brill

VP, Product Development

• – –

2009-05-18

4

D

$3.79

$17,840

I/I

(4,707)

40,000

-

Almon Einat Brill

VP, Product Development

• – –

2009-05-18

4

OE

$0.40

$17,838

I/I

44,707

44,707

-

VP, Chief Financial Officer

• – –

2009-05-18

4

S

$4.00

$120,000

I/I

(30,000)

0

-

VP, Chief Financial Officer

• – –

2009-05-18

4

D

$3.79

$39,219

I/I

(10,348)

30,000

-

VP, Chief Financial Officer

• – –

2009-05-18

4

OE

$0.97

$39,218

I/I

40,348

40,348

-

182 Records found	1 2 3 4 5 6 7 8	Page 5 of 8

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.